Xuyun Liu

Xuyun Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xuyun Liu has a total of 48 co-authors. Here are the top co-authors by number of shared publications:

  • Jiankang Liu

    Center for Mitochondrial Biology and Medicine, The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi’an Jiaotong University, Xi’an 710049, China

    5 shared publications
  • Feng Gao

    Key Laboratory of Aerospace Medicine of the Ministry of Education, School of Aerospace Medicine, Fourth Military Medical University, Xi’an, China

    4 shared publications
  • Xing Zhang

    Key Laboratory of Aerospace Medicine of the Ministry of Education, School of Aerospace Medicine, Fourth Military Medical University, Xi'an, 710032, China

    4 shared publications
  • Lin Zhao

    Center for Mitochondrial Biology and Medicine, The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi’an Jiaotong University, Xi’an 710049, China

    2 shared publications
  • Xinyu Liao

    Center for Mitochondrial Biology and Medicine, The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Department of Pharmacology, School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an, 710049, China

    2 shared publications
  • Yang Zhang

    Department of Medical Electronics, School of Biomedical Engineering, Air Force Medical University, Xi’an 710032, China

    2 shared publications

Latest Publications

  • Open Access

    Shear Stress‐Stimulated Trafficking of Endothelial Piezo1 to Splenic Capsule Boosts Spleen Contraction and Exercise Endurance

    by Jing Lou, Mingzong Yang, Yang Hu, Xuyun Liu, Han Li, Zihang Feng, Yuxin Xi, Changyang Xing, Lijun Yuan, Jia Li, et al.

    Haemodynamic shear stress, sensed by vascular endothelial cells (ECs), is crucial for the functional integrity of ECs and the systemic benefits of exercise. Here, we observed that shear stress triggers the release of medium/large extracellular vesicles (m/lEVs), from ECs via activation of the mechanosensitive ion channel Piezo1. Endothelial Piezo1 activation induces Piezo1 translocation to the cell periphery, facilitating its trafficking from the vascular ECs to the smooth muscle cells in the splenic capsule. Within the splenic capsule, the translocated Piezo1 acts as a downstream effector of α1‐adrenergic receptor, boosting exercise‐induced spleen contraction and enhancing exercise endurance. Genetic or pharmacological inhibition of Piezo1 trafficking from ECs impaired spleen contraction during exercise and reduced exercise endurance in mice. Additionally, exercise‐induced m/lEV release contributes to safeguard endothelial function through modulating intracellular Piezo1 homeostasis. Furthermore, positive correlations between exercise‐induced increases in circulating Piezo1‐enriched m/lEVs and the degree of spleen contraction were also observed in human volunteers. These findings unveil a vasculo‐splenic axis during exercise, in which EC‐derived m/lEVs shuttle Piezo1 to maintain endothelial function and exercise endurance, highlighting a novel role of Piezo1 in inter‐organ communication.

  • Open Access

    Mitochondrial Quality Control Links Exercise to Sterile Inflammation in the Cardiovascular System: A Narrative Review

    by Ying Wen, Pengfei Zhang, Xinyu Liao, Jiankang Liu, Yang Zhang, Xuyun Liu

    Preservation of mitochondrial integrity has emerged as a central hub in the anti-inflammatory effect of exercise. This narrative review advances a framework in which mitochondrial damage-associated molecular patterns (mtDAMPs) serve as the mechanistic bridge between exercise and inflammation. Mitochondrial dysfunction releases mtDAMPs, including mitochondrial DNA (mtDNA), reactive oxygen species, cardiolipin, N-formyl peptides, and ATP, which activate cGAS–STING, the NLRP3 inflammasome, TLR9, AIM2, ZBP1, and NF-κB signaling. Crosstalk among these pathways allows mild mitochondrial damage to escalate into chronic inflammation. Exercise opposes this cascade through the AMPK–PGC-1α axis, which coordinately activates four mitochondrial quality control (MQC) modules: biogenesis, antioxidant defense, dynamics, and mitophagy. The cardiovascular system illustrates this framework, as myocardial inflammation runs mainly through mtDNA–cGAS–STING signaling and vascular inflammation through oxidized mtDNA–NLRP3 signaling, while cardiovascular aging engages both axes at once. Throughout, exercise refers to repeated training rather than to a single bout, and the framework targets middle-aged and older adults with, or at risk of, cardiovascular disease. The upstream half of the sequence, in which training raises mitochondrial content and antioxidant capacity, rests on human muscle biopsy data; the downstream half remains largely preclinical. MQC is therefore proposed as a testable target rather than an established one.

  • 6-Gingerol ameliorates endothelial injury in hyperlipidemia mice via Nrf2 activation and inflammation modulation

    by Xi He, Yuepeng Shang, Xinyu Liao, Guanting Liu, Qingyao Yang, Jiaqi Liu, Xiaolong Xu, Xuyun Liu

    Cardiovascular diseases remain the leading cause of global mortality, with endothelial dysfunction recognized as a critical initiating event. Hyperlipidemia-induced endothelial lipotoxicity triggers oxidative stress and inflammation, thereby accelerating vascular injury. Given the central role of endothelial cells in maintaining vascular homeostasis, they represent a key therapeutic target for mitigating systemic lipotoxicity. However, specific strategies aimed at countering endothelial lipotoxicity remain limited, highlighting an urgent need for novel pharmacological interventions. 6-Gingerol, a primary bioactive constituent of ginger (Zingiber officinale) and related plants, exhibits potent antioxidant, anti-inflammatory, and anticancer properties. Nevertheless, its potential protective effects against hyperlipidemia-induced endothelial injury and the underlying mechanisms remain incompletely understood. In this study, we investigated the protective effects of 6-gingerol and explored its mechanisms of action using both in vivo and in vitro models of endothelial dysfunction. Our results demonstrated that 6-gingerol effectively ameliorates inflammation and oxidative stress associated with endothelial dysfunction induced by hyperlipidemia. Mechanistically, under Nrf2 knockdown conditions, the antioxidant effects of 6-gingerol were abolished. Similarly, inhibition of Erk with U0126 blocked 6-gingerol-mediated nuclear translocation of Nrf2 and its antioxidant activity, underscoring the critical role of the Erk–Nrf2 axis in mediating these effects. Moreover, transcriptomic analysis and pharmacological interventions using a p38 MAPK inhibitor and an NF-κB inhibitor revealed that 6-gingerol suppresses the release of inflammatory mediators, such as IL-6, via the p38 MAPK–NF-κB signaling pathway. In summary, our study provides evidence that 6-gingerol ameliorates lipotoxicity-induced endothelial injury through coordinated modulation of the Erk–Nrf2 and p38–NF-κB signaling pathways, highlighting its potential as a novel preventive candidate for endothelial dysfunction in cardiovascular diseases.


  • Open Access

    Design, Synthesis, and Biological Evaluation of Novel Hydroxytyrosol Derivatives as Protectors for Vascular Endothelium Against Lipid Overload

    by Xi-Xi Hou, Shuang Wang, Xiao-Xia Ma, Ying Wen, Zhi-Jun Li, Xu-Yun Liu, Xing Zhang, Yang Zhang, Xiang-Yang Qin

    Background and Objective: Hydroxytyrosol (HT) is reported to protect endothelial cells against metabolic overload through inhibiting inflammation. However, the hydrophilic nature of HT limits its oral bioavailability and biological efficiency. The aim of the study was to design and synthesize novel hybrid molecules to improve HT’s biological efficiency. Materials and Methods: A pharmacophore connection strategy was used to design and synthesize novel hybrid molecules by combining HT or its analogues with adamantane (ADM). Palmitic acid (PA) was used to induce lipid overload in HAEC cells, and P407 was used to induce acute hyperlipidemia in C57 mice. Results: We found that DP-ADM, combining ADM and dopamine (a HT analogues), exhibited potent protective effects against metabolic overload-induced endothelial dysfunction. DP-ADM showed low toxicity and inhibited inflammation in response to PA overload in cultured endothelial cells. Additionally, it (30 mg/kg) decreased circulating lipids to an extent similar to HT in a mouse model of hyperlipidemia and was superior to HT in decreasing circulating inflammatory cytokine. It was also superior to HT in improving vascular endothelial function in mice with hyperlipidemia. Mechanistically, DP-ADM inactivated MAPK signaling, as evidenced by downregulated phosphorylation of p38 and Erk. Inhibition of MAPK or NF-κB abolished the anti-inflammatory effect of DP-ADM. Specifically, DP-ADM activated FoxO1 signaling and increased mitochondrial biogenesis in endothelial cells. Conclusion: Overall, DP-ADM is a superior form of HT, highlighting its potential therapeutic use in improving endothelial function in metabolic diseases.


  • Diet, Epigenetics, and Cardiovascular Disease

    by Xuyun Liu, Xing Zhang, Jiankang Liu, Feng Gao


  • Mitochondria as a sensor, a central hub and a biological clock in psychological stress-accelerated aging

    by Xuyun Liu, Xing Zhang, Lin Zhao, Jiangang Long, Zhihui Feng, Jiacan Su, Feng Gao, Jiankang Liu


  • Open Access

    Hydrogen Protection Boosts the Bioactivity of Chrysanthemum morifolium Extract in Preventing Palmitate-Induced Endothelial Dysfunction by Restoring MFN2 and Alleviating Oxidative Stress in HAEC Cells

    by Yilin Gao, Oumeng Song, Min Wang, Xin Guo, Guanfei Zhang, Xuyun Liu, Jiankang Liu, Lin Zhao

    As the most important natural antioxidants in plant extracts, polyphenols demonstrate versatile bioactivities and are susceptible to oxidation. The commonly used ultrasonic extraction often causes oxidation reactions involving the formation of free radicals. To minimize the oxidation effects during the ultrasonic extraction process, we designed a hydrogen (H2)-protected ultrasonic extraction method and used it in Chrysanthemum morifolium extraction. Hydrogen-protected extraction improved the total antioxidant capacity, 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity, and polyphenol content of Chrysanthemum morifolium water extract (CME) compared with air and nitrogen (N2) conditions. We further investigated the protective effects and mechanisms of CME on palmitate (PA)-induced endothelial dysfunction in human aorta endothelial cells (HAECs). We found that hydrogen-protected CME (H2-CME) best-prevented impairment in nitric oxide (NO) production, endothelial NO synthase (eNOS) protein level, oxidative stress, and mitochondrial dysfunction. In addition, H2-CME prevented PA-induced endothelial dysfunction by restoring mitofusin-2 (MFN2) levels and maintaining redox balance.


  • Open Access

    Mitochondria-Targeted Triphenylphosphonium-Hydroxytyrosol Prevents Lipotoxicity-Induced Endothelial Injury by Enhancing Mitochondrial Function and Redox Balance via Promoting FoxO1 and Nrf2 Nuclear Translocation and Suppressing Inflammation via Inhibiting p38/NF-кB Pathway

    by Xuyun Liu, Jing Gao, Yizhen Yan, Eleftheria A. Georgiou, Jing Lou, Mengya Feng, Xing Zhang, Feng Gao, Jiankang Liu, Ioannis K. Kostakis, et al.

    Hyperlipidemia results in endothelial dysfunction, which is intimately associated with disturbed mitochondrial homeostasis, and is a real risk factor for cardiovascular diseases (CVDs). Triphenylphosphonium (TPP+)-HT, constructed by linking a mitochondrial-targeting moiety TPP+ to hydroxytyrosol (HT), enters the cell and accumulates in mitochondria and is thus an important candidate drug for preventing hyperlipidemia-induced endothelial injury. In the present study, we found that TPP-HT has a better anti-inflammatory effect than HT. In vivo, TPP-HT significantly prevented hyperlipidemia-induced adverse changes in the serological lipid panel, as well as endothelial and mitochondrial dysfunction of the thoracic aorta. Similarly, in vitro, TPP-HT exhibited similar protective effects in palmitate (PA)-induced endothelial dysfunction, particularly enhanced expression of the mitochondrial ETC complex II, recovered FoxO1 expression in PA-injured human aorta endothelial cells (HAECs) and promoted FoxO1 nuclear translocation. We further demonstrated that FoxO1 plays a pivotal role in regulating ATP production in the presence of TPP-HT by using the siFoxO1 knockdown technique. Simultaneously, TPP-HT enhanced Nrf2 nuclear translocation, consistent with the in vivo findings of immunofluorescence, and the antioxidant effect of TPP-HT was almost entirely blocked by siNrf2. Concomitantly, TPP-HT’s anti-inflammatory effects in the current study were primarily mediated via the p38 MAPK/NF-κB signaling pathway in addition to the FoxO1 and Nrf2 pathways. In brief, our findings suggest that mitochondria-targeted TPP-HT prevents lipotoxicity induced endothelial dysfunction by enhancing mitochondrial function and redox balance by promoting FoxO1 and Nrf2 nuclear translocation.